CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 1 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $11,505,000 | +11.1% | 3,606,707 | 0.0% | 0.87% | +44.3% |
Q4 2021 | $10,351,000 | -27.7% | 3,606,707 | 0.0% | 0.60% | -28.7% |
Q3 2021 | $14,319,000 | -33.4% | 3,606,707 | 0.0% | 0.85% | -31.6% |
Q2 2021 | $21,496,000 | -50.9% | 3,606,707 | 0.0% | 1.24% | -52.9% |
Q1 2021 | $43,785,000 | -16.8% | 3,606,707 | 0.0% | 2.63% | -16.0% |
Q4 2020 | $52,622,000 | +26.8% | 3,606,707 | 0.0% | 3.13% | +1.8% |
Q3 2020 | $41,513,000 | – | 3,606,707 | – | 3.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 1,501,716 | $17,284,000 | 8.25% |
venBio Partners LLC | 3,673,374 | $42,281,000 | 6.42% |
Omega Fund Management, LLC | 1,335,050 | $15,366,000 | 4.16% |
Sofinnova Investments, Inc. | 3,606,707 | $41,513,000 | 3.08% |
Novo Holdings A/S | 2,170,100 | $24,978,000 | 1.24% |
CLOUGH CAPITAL PARTNERS L P | 1,313,286 | $14,864,000 | 1.07% |
SECTORAL ASSET MANAGEMENT INC | 600,687 | $6,914,000 | 0.59% |
CAAS CAPITAL MANAGEMENT LP | 44,966 | $518,000 | 0.01% |
Zimmer Partners, LP | 25,000 | $288,000 | 0.00% |
Ensign Peak Advisors, Inc | 119,915 | $1,380,000 | 0.00% |